|
265 Pharmacists are “rubbish at gathering evidence” Pharmacists are not good at gathering evidence for the work they undertake. So said Andy Murdock, Lloydspharmacy’s pharmacy director, at a pharmacy engagement meeting for Lord Darzi’s NHS Next Stage Review for England, held in London last week
PJ 2008;280:265
Full Text
265 DoH gives notice on the PPRS New
arrangements for pricing medicines in the UK will begin in September
2008, following notice of termination of the current pricing scheme by
the Department of Health
PJ 2008;280:265
Full Text
265 Two Council members decide not to stand Two of the five members of the Royal Pharmaceutical Society’s Council who have come to the end of their current terms of office have chosen not to stand for re-election
PJ 2008;280:265
Full Text
266 Nitrofurantoin switch
application made for cystitis Views are being sought
on the reclassification of nitrofurantoin to a pharmacy medicine for the treatment
of bacterial cystitis
PJ 2008;280:266
Full Text
266 Views on specials manufacturing sought Specials manufacturing — making unlicensed medicines to order — in the UK is being reviewed by the Medicines and Healthcare products Regulatory Agency because it believes the current rules may no longer be appropriate
PJ 2008;280:266
Full Text
266 Advice issued on capacity improvement programme Advice
for community pharmacy contractors in England on how to minimise errors and problems
associated with changes to the processing of prescriptions has been issued by
the Pharmaceutical Services Negotiating Committee
PJ 2008;280:266
Full Text
266 Pivotal role for pharmacists in helping
smokers to break their habit Pharmacists have a
pivotal role to play in continuing to push messages about the dangers of smoking
and helping smokers quit, according to a pharmacist involved in drawing up new
smoking cessation guidance
PJ 2008;280:266
Full Text
267 PSNC issues practical
guide on release 2 of EPS Detailed guidance on
how release 2 of the electronic prescription service will work has been published
by the Pharmaceutical Services Negotiating Committee
PJ 2008;280:267
Full Text
267 New prescription security advice issued
by NHS SMS Guidance for pharmacists in England
on what they can do to improve prescription security advises them to get sample
signatures from all prescribers in their locality
PJ 2008;280:267
Full Text
267 Pandemic demand will need to be managed Surges
in demand for health services during an influenza pandemic will require a co-ordinated
response from primary care organisations, local pharmaceutical committees and
community pharmacies, the pharmacy sector has agreed
PJ 2008;280:267
Full Text
268 IPF calls for emergency
funding for independents Changes to Category M reimbursement prices, implemented last October, are having a significant impact on independent contractors’ ability to pay their bills and manage cash flows, the Independent Pharmacy Federation stated this week. The IPF has called for the Department of Health to provide emergency funding for independent contractors so they can continue to provide NHS pharmacy services
PJ 2008;280:268
Full Text
268 Drug Tariff no longer to be distributed
free in Wales Free paper copies of the Drug Tariff
will no longer be distributed in Wales, the Welsh Assembly Government has revealed
PJ 2008;280:268
Full Text
268 Clinical pharmacists save money and lives Clinical
pharmacists are saving lives and generating massive savings to drug budgets,
said Lars Heslet, medical director of intensive care, National University Hospital,
Copenhagen
PJ 2008;280:268
Full Text
268 Drug promotion complaints Complaints
by two pharmacy companies about medicines promotions on the internet by rivals
have been upheld by the Medicines and Healthcare products Regulatory Agency
PJ 2008;280:268
Full Text
269 Oral ketoconazole use
restricted over liver concerns Oral ketoconazole
(Nizoral) should no longer be used as first-line antifungal treatment or to treat
superficial infections, the Medicines and Healthcare products Regulatory Agency
has decided following a review of evidence
PJ 2008;280:269
Full Text
269 Rare tendon problems identified with statins Statins
may cause tendon complications, although these effects are rare, say French researchers.
Tendon impairment following statin use has been reported anecdotally but no large-scale
studies have previously been carried out
PJ 2008;280:269
Full Text
269 Switch antidepressant and add CBT if first
SSRI fails for teens Adolescents with major depression
who have not responded to initial treatment with a selective serotonin reuptake
inhibitor may benefit from switching to another SSRI, or venlafaxine, and adding
cognitive behavioural therapy (CBT), according to a study published
PJ 2008;280:269
Full Text
269 Genomic medicine risks and benefits to be
looked at by Lords Potential benefits and risks
of genomic medicines are to be examined by a parliamentary subcommittee
PJ 2008;280:269
Full Text
269 MHRA and Society co-operation Working
relationships between the Royal Pharmaceutical Society and the Medicines and
Healthcare products Regulatory Agency are to be strengthened after the two organisations
signed a memorandum of understanding this week to enhance exchange of information
PJ 2008;280:269
Full Text
269 Insulin pen with a memory Remembering
to inject insulin could become easier for diabetes patients with the launch of
a reusable insulin pen with a digital memory
PJ 2008;280:269
Full Text
269 Epoetin mortality and VTE risks Treatment
of chemotherapy-associated anaemia with epoetin and darbepoetin is associated
with increased risks of venous thromboembolism (VTE) and mortality, a study reveals
PJ 2008;280:269
Full Text
270 Graduate funding re-examined Future graduates who want to retrain as pharmacists in England — but face the possibility that changes in funding will prevent them — have been thrown a lifeline
PJ 2008;280:270
Full Text
270 Society museum display marks science week “Developing treatments”, a new museum display, has been launched by the Royal Pharmaceutical Society to mark National Science and Engineering Week, which runs from 7–16 March 2008
PJ 2008;280:270
Full Text
270 Welsh innovations set to help pharmacy staff Two
pharmacy projects were among the winners at the Welsh Innovations in Healthcare
awards last week
PJ 2008;280:270
Full Text
270 NPA and BMA collaborate on resource for
joint working Communication between pharmacy and
general practice could be improved by means of a new workbook, developed as a
joint venture between the National Pharmacy Association and the General Practitioners
Committee of the British Medical Association
PJ 2008;280:270
Full Text
270 Pharmacy lobbies Lib Dems Pharmacy organisations in Scotland joined forces last weekend to lobby politicians about pharmacists’ role in public health and chronic disease management
PJ 2008;280:270
Full Text
270 New-design MUR forms can now be used across
Wales New-design medicines use review forms can
now be used in Wales, following legislative changes that will appear in the April
2008 Drug Tariff
PJ 2008;280:270
Full Text |
The
Pharmaceutical Journal